Investor Relations

Press Releases

Date Title and Summary View
Mar 09, 2016

Cash Expected to Fund Operations Through the End of 2017

Mar 03, 2016

Presentation Scheduled on Monday, March 14, 2016 at 7:30 AM Pacific Time

Feb 24, 2016

Andrew Schiff, M.D. to Step Down From the Board

Feb 16, 2016

Presentation Scheduled on Tuesday, February 23, 2016 at 8:00 AM ET 

Feb 04, 2016
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the underwriters of its previously announced
Jan 22, 2016
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the pricing of its underwritten public offering
Jan 21, 2016
PRINCETON, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that it intends to offer and sell $30 million of
Jan 15, 2016

Presentation Scheduled on Monday, January 18, 2016 at 11:30 AM ET

Dec 01, 2015
PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has received net proceeds of approximately $6 million in
Nov 17, 2015
PRINCETON, N.J., Nov. 17, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, President and Chief Executive